Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schretlen, D. J.
Right arrow Articles by Jinnah, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schretlen, D. J.
Right arrow Articles by Jinnah, H. A.
Related Collections
Right arrow Stroke prevention
Right arrow MRI
Right arrow All Clinical Neurology
Right arrow All Neuropsychology/Behavior
Right arrow All Cerebrovascular disease/Stroke
Right arrow Clinical trials Observational study (Cohort, Case control)
Right arrow All Cognitive Disorders/Dementia
Right arrow Vascular dementia
Right arrow Cognitive aging
Right arrow MCI (mild cognitive impairment)
Right arrow All epidemiology
Right arrow Risk factors in epidemiology
NEUROLOGY 2007;69:1418-1423
© 2007 American Academy of Neurology

Serum uric acid and brain ischemia in normal elderly adults

D. J. Schretlen, PhD, A. B. Inscore, PsyD, T. D. Vannorsdall, PhD, M. Kraut, MD, PhD, G. D. Pearlson, MD, B. Gordon, MD, PhD and H. A. Jinnah, MD, PhD

From the Departments of Psychiatry and Behavioral Sciences (D.J.S., A.B.I., T.D.V., G.D.P.), Radiology and Radiological Sciences (D.J.S., M.K.), and Neurology (B.G., H.A.J.), Johns Hopkins University School of Medicine, Baltimore, MD, and Olin Neuropsychiatry Research Center (G.D.P.), Hartford Hospital/Institute of Living, and Department of Psychiatry (G.D.P.), Yale University School of Medicine, New Haven, CT.

Address correspondence and reprint requests to Dr Schretlen, Johns Hopkins Hospital, 600 N. Wolfe St., Meyer 218, Baltimore, MD 21287-7218

Background: Uric acid (UA) has antioxidant properties yet when elevated is associated with vascular disease and stroke. Further, even high normal UA is associated with increased risk of mild cognitive dysfunction in elderly adults.

Method: In this cross-sectional, observational study, we examined the relationship between serum UA and aggregate volume of white matter hyperintense (WMH) signals observed on proton density and T2-weighted brain MR images in a community sample of 177 adults ages 20 to 92. Using logistic regression, we tested whether participants with UA concentrations in the highest quartile of the sample—but still normal—would have increased WMH volumes.

Results: Compared with those with low to moderate levels, participants with high normal serum UA were more likely to fall in the highest quartile of WMH volume. The odds ratios (95% CIs) of increased WMH were 2.6 (1.2 to 5.4) for total, 2.5 (1.2 to 5.1) for periventricular, and 2.8 (1.4 to 5.9) for subcortical WMH volume. After controlling for age, sex, race, education, body mass, hypertension, and diabetes, the multivariate-adjusted odds of large total and subcortical WMH volumes remained elevated. Finally, high normal UA increased the odds of having excessive ischemic burden four- to fivefold in adults ages 60 and older.

Conclusions: These findings demonstrate that mildly elevated serum uric acid is associated with increased burden of cerebral ischemic pathology, particularly in older adults. We outline the potential pathogenesis of this association. A clinical trial of antihyperuricemic medication to treat or prevent chronic brain ischemia might be warranted.

GLOSSARY: ICC = intraclass correlation; OR = odds ratio; UA = uric acid; WMH = white matter hyperintense.


dschret{at}jhmi.edu

Supported by NIH/NIMH grants MH60504, MH52886, MH43775, and MH068522, the Therapeutic Cognitive Neuroscience Fund, and the Benjamin & Adith Miller Family Endowment on Aging, Alzheimer’s and Autism Research.

Disclosure: The authors report no conflicts of interest.

Received December 4, 2006. Accepted in final form April 27, 2007.




This article has been cited by other articles:


Home page
Arch NeurolHome page
M. Schiess and I. Oh
Serum Uric Acid and Clinical Progression in Parkinson Disease: Potential Biomarker for Nigrostriatal Failure
Arch Neurol, June 1, 2008; 65(6): 698 - 699.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by AAN Enterprises, Inc.